Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPEI.L Regulatory News (JPEI)

  • There is currently no data for JPEI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Oct 2020 09:08

RNS Number : 3635B
JPMorgan Elect PLC
07 October 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN ELECT PLC

 

("the Company")

 

NEW DIRECTOR APPOINTMENT (LR 9.6.11 and 9.6.13)

 

 

Legal Entity Identifier: 549300FIUYKKL39ILD07

Information disclosed in accordance with LR 9.6.11 and LR 9.6.13

The Board of JPMorgan Elect Plc is pleased to announce the appointment of Mrs. Davina Walter and Mr. Steve Bates as Non-Executive Directors of the Company with effect from 15th October 2020.

Mrs. Walter is currently engaged as an investment consultant having started her career at Cazenove & Co where she spent more than 11 years involved in US equity research. She spent over 16 years as an investment manager of US equity portfolios, most recently as a Managing Director at Deutsche Asset Management. She has been actively involved with investment trusts since 1985 and is currently Chairman and a director of Aberdeen Diversified Income & Growth Trust plc. 

 

Mr. Steve Bates is currently serving as Director and Chief Investment Officer of GuardCap Asset Management Limited and is also a Director of GuardCap UCITS plc and Biotech Growth Trust plc. He has served as the head of emerging markets at JP Morgan Fleming Asset Management, a business he established for predecessor organization (Flemings) in 1990. Steve is non-executive Chairman of Vinacapital Vietnam Opportunity Fund Limited and of Third Point Offshore Investors Limited.

 

Commenting on the proposed appointment Mr. Alan Hodson, Chairman of the Company stated:

 

"I am delighted that Davina and Steve are joining the Board of JPMorgan Elect plc. They bring a significant range of corporate and strategic knowledge and perspective to the Board. I am confident that both Davina and Steve will be excellent additions."

 

Mrs. Walter holds 1,500 Managed Growth shares and 3,500 Managed Income shares in the Company.

 

Mr. Bates holds 250,596 Managed Growth shares in the Company.

 

There are no other disclosures required to be made for the appointments in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

07 October 2020

For further information, please contact:

 

Priyanka Vijay Anand

JPMorgan Funds Limited

Company Secretary

 

Telephone 0207 742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGIBDGUGGDGGR
Date   Source Headline
19th Dec 20221:29 pmRNSScheme Entitlements
19th Dec 20221:21 pmRNSResult of Meeting
14th Dec 202212:02 pmRNSNet Asset Value(s)
13th Dec 202211:37 amRNSNet Asset Value(s)
12th Dec 202212:21 pmRNSGearing Announcement
12th Dec 202211:50 amRNSNet Asset Value(s)
9th Dec 20221:34 pmRNSResult of Meeting
9th Dec 202212:17 pmRNSNet Asset Value(s)
9th Dec 202211:44 amRNSBlock listing Interim Review
9th Dec 202211:40 amRNSBlock listing Interim Review
8th Dec 20224:07 pmRNSTransaction in Own Shares
8th Dec 202211:26 amRNSNet Asset Value(s)
7th Dec 202211:40 amRNSNet Asset Value(s)
6th Dec 202211:38 amRNSNet Asset Value(s)
5th Dec 20225:14 pmRNSTransaction in Own Shares
5th Dec 202212:27 pmRNSGearing announcement
5th Dec 202211:46 amRNSNet Asset Value(s)
2nd Dec 202211:53 amRNSNet Asset Value(s)
1st Dec 20224:37 pmRNSTransaction in Own Shares
1st Dec 20224:35 pmRNSDirector Declaration
1st Dec 202211:26 amRNSNet Asset Value(s)
1st Dec 202210:10 amRNSTotal Voting Rights
30th Nov 20225:00 pmRNSTransaction in Own Shares
30th Nov 202211:20 amRNSNet Asset Value(s)
29th Nov 20224:37 pmRNSTransaction in Own Shares
29th Nov 202211:08 amRNSNet Asset Value(s)
28th Nov 20224:59 pmRNSChange in Nominal Value
28th Nov 20224:41 pmRNSTransaction in Own Shares
28th Nov 202212:54 pmRNSGearing announcement
28th Nov 202211:45 amRNSNet Asset Value(s)
25th Nov 20221:55 pmRNSConversion of Securities
25th Nov 202211:53 amRNSNet Asset Value(s)
24th Nov 202211:15 amRNSNet Asset Value(s)
23rd Nov 202210:48 amRNSNet Asset Value(s)
22nd Nov 202211:19 amRNSNet Asset Value(s)
21st Nov 202212:10 pmRNSGearing announcement
21st Nov 202211:37 amRNSNet Asset Value(s)
18th Nov 202210:58 amRNSNet Asset Value(s)
17th Nov 202211:07 amRNSNet Asset Value(s)
16th Nov 202210:55 amRNSNet Asset Value(s)
15th Nov 20225:10 pmRNSPublication of Circular
15th Nov 202210:54 amRNSNet Asset Value(s)
14th Nov 202211:51 amRNSGearing announcement
14th Nov 202211:46 amRNSTen Largest Investments
14th Nov 202210:46 amRNSNet Asset Value(s)
11th Nov 202211:49 amRNSNet Asset Value(s)
10th Nov 20223:46 pmRNSDividend Declaration
10th Nov 202210:30 amRNSNet Asset Value(s)
9th Nov 202211:08 amRNSNet Asset Value(s)
8th Nov 202210:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.